10.5681/APB.2013.031
Heidari Majd, Mostafa
Mostafa
Heidari Majd
Barar, Jaleh
Jaleh
Barar
Asgari, Davoud
Davoud
Asgari
Valizadeh, Hadi
Hadi
Valizadeh
Rashidi, Mohammad Reza
Mohammad Reza
Rashidi
Kafil, Vala
Vala
Kafil
Shahbazi, Javid
Javid
Shahbazi
Omidi, Yadollah
Yadollah
Omidi
Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells
Tabriz University of Medical Sciences
2013
JournalArticle
610 Medical sciences; Medicine
2013-02-07
2013
en
text/html
Advanced Pharmaceutical Bulletin; eISSN 2251-7308
Purpose: To achieve simultaneous imaging and therapy potentials, targeted fluoromagnetic nanoparticles were synthesized and examined in human breast cancer MCF-7 cells. Methods: Fe3O4 nanoparticles (NPs) were synthesized through thermal decomposition of Fe(acac)3. Then, magnetic nanoparticles (MNPs) modified by dopamine-poly ethylene glycol (PEG)-NH2; finally, half equivalent fluorescein isothiocyanate (FITC) and half equivalent folic acid were conjugated to one equivalent of it. The presence of Fe3O4-DPA-PEG-FA/FITC in the folate receptor (FR) positive MCF-7 cells was determined via fluorescent microscopy to monitor the cellular interaction of MNPs. Results: FT-IR spectra of final compound confirmed existence of fluorescein on folic acid grafted MNPs. The Fe3O4-DPA-PEG-FA/FITC NPs, which displayed a size rang about 30-35 nm using scanning electron microscopy (SEM) and transmission electron microscopy (TEM), were able to actively recognize the FR-positive MCF-7 cells, but not the FR-negative A549 cells. Conclusion: The uniform nano-sized Fe3O4-DPA-PEG-FA/FITC NPs displayed great potential as theranostics and can be used for targeted imaging of various tumors that overexpress FR.
Advanced Pharmaceutical Bulletin; eISSN 2251-7308